DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 121 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2015. The put-call ratio across all filers is 0.06 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $605,000 | -62.2% | 153,252 | +0.3% | 0.00% | -50.0% |
| Q3 2016 | $1,602,000 | -25.6% | 152,732 | +3.4% | 0.00% | -33.3% |
| Q2 2016 | $2,153,000 | -14.9% | 147,646 | +12.3% | 0.00% | 0.0% |
| Q1 2016 | $2,529,000 | -18.4% | 131,426 | +2.5% | 0.00% | -25.0% |
| Q4 2015 | $3,098,000 | -0.7% | 128,219 | +0.8% | 0.00% | 0.0% |
| Q3 2015 | $3,121,000 | +27.9% | 127,170 | +22.1% | 0.00% | +33.3% |
| Q2 2015 | $2,441,000 | +14.1% | 104,195 | +9.3% | 0.00% | 0.0% |
| Q1 2015 | $2,139,000 | +45.8% | 95,366 | +9.6% | 0.00% | +50.0% |
| Q4 2014 | $1,467,000 | – | 87,011 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 11,771,708 | $115,951,000 | 7.60% |
| Chicago Capital, LLC | 5,878,959 | $57,908,000 | 2.26% |
| PFM Health Sciences, LP | 2,990,770 | $29,459,000 | 0.92% |
| Avidity Partners Management LP | 3,400,000 | $33,490,000 | 0.90% |
| MIZUHO MARKETS AMERICAS LLC | 617,358 | $6,081,000 | 0.72% |
| Rhenman & Partners Asset Management AB | 750,000 | $7,388,000 | 0.50% |
| Jackson Creek Investment Advisors LLC | 115,333 | $1,136,000 | 0.42% |
| Rock Springs Capital Management LP | 1,679,921 | $16,547,000 | 0.33% |
| FEDERATED HERMES, INC. | 14,243,800 | $140,301,000 | 0.26% |
| JACKSON SQUARE CAPITAL, LLC | 80,400 | $792,000 | 0.25% |